Loading…
Reported covered position: Dir. of Scheduling & Executive Assistant, Sen. Charles Schumer; Special Assistant, Democratic Staff, Senate Committee on Rules and Administration; Volunteer Recruitment and Training Aide, Joint Congressional Committee on Inaugural Ceremonies
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: 340B HEALTH · Firm: 340B HEALTH
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2018 · third_quarter · Q3
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 and proposed 2019 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
340B HEALTH via
Source: Senate LDA
Client: 340B HEALTH · Firm: 340B HEALTH
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 and proposed 2019 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: 340B HEALTH · Firm: 340B HEALTH
The 340B Drug Pricing Program, FY18 LHHS Appropriations, FY19 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties, S.2312, S.2453, H.R.4710, H.R.4392
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 and proposed 2019 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
The 340B Drug Pricing Program, FY18 LHHS Appropriations, FY19 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties, S.2312, S.2453, H.R.4710, H.R.4392
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 and proposed 2019 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 and proposed 2019 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 and proposed 2019 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
To amend the Public Health Service Act to ensure appropriate care by certain 340B covered entities for victims of sexual assault, and for other purposes.
Client: 340B HEALTH · Firm: 340B HEALTH
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
To amend the Public Health Service Act to ensure appropriate care by certain 340B covered entities for victims of sexual assault, and for other purposes.
Client: 340B HEALTH · Firm: 340B HEALTH
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 and proposed 2019 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
Helping Ensure Low-income Patients have Access to Care and Treatment
Client: 340B HEALTH · Firm: 340B HEALTH
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
Helping Ensure Low-income Patients have Access to Care and Treatment
Client: 340B HEALTH · Firm: 340B HEALTH
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 and proposed 2019 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
Helping Ensure Low-income Patients have Access to Care and Treatment
Client: 340B HEALTH · Firm: 340B HEALTH
The 340B Drug Pricing Program, FY18 LHHS Appropriations, FY19 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties, S.2312, S.2453, H.R.4710, H.R.4392
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 and proposed 2019 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
The 340B Drug Pricing Program, FY18 LHHS Appropriations, FY19 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties, S.2312, S.2453, H.R.4710, H.R.4392
2018 · second_quarter · Q2
The 340B Drug Pricing Program; FY19 LHHS Appropriations; final 2018 Outpatient Prospective Payment System Rule; proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties; delay of 340B ceiling price database; S.2312, S.2453, H.R.4710, H.R.4392, H.R.5598, H.R.6071, H.R.6240, H.R.6273, and other legislation relevant to the 340B drug pricing program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2018 · first_quarter · Q1
The 340B Drug Pricing Program, FY18 LHHS Appropriations, FY19 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties, S.2312, S.2453, H.R.4710, H.R.4392
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2017 · fourth_quarter · Q4
The 340B Drug Pricing Program, FY18 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, final rule and new proposed rule concerning 340B ceiling price calculations and manufacturer civil monetary penalties
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2017 · third_quarter · Q3
The 340B Drug Pricing Program, FY18 LHHS Appropriations, Proposed 2018 Outpatient Prospective Payment System Rule, Interim Final Rule Delaying Effective Dates of 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE